WWC
MBIO icon

Waypoint Wealth Counsel’s Mustang Bio MBIO Stock Holding History

Waypoint Wealth Counsel’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32
Closed -$8.85K – 95
2023
Q1 		$8.85K Sell
32
-5
-14% -$2.05K 0.01% 92
2022
Q4 		$10.9K Buy
+37
New +$12.6K 0.01% 94

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Waypoint Wealth Counsel's MBIO Position: Q2 2023 in Review

Waypoint Wealth Counsel sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 32 shares — an estimated $8.85K sold.

Waypoint Wealth Counsel first reported a position in MBIO in Q4 2022 and held it in 2 quarters. The position peaked at $10.9K in Q4 2022. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Waypoint Wealth Counsel reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
  • Waypoint Wealth Counsel sold 32 Mustang Bio shares in Q2 2023, an estimated $8.85K.
  • Waypoint Wealth Counsel first reported a position in Mustang Bio in Q4 2022 and held it in 2 quarters.
  • Waypoint Wealth Counsel's Mustang Bio position peaked at $10.9K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Waypoint Wealth Counsel's 13F filing for Q2 2023, filed 2 Apr 2024.